PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

35 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Adebahr, S.* et al.: The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy. Eur. J. Nucl. Med. Mol. Imaging 51, 558-567 (2024)
2.
Carli, G.* et al.: Occipital hypometabolism is a risk factor for conversion to Parkinson’s disease in isolated REM sleep behaviour disorder. Eur. J. Nucl. Med. Mol. Imaging 50, 3290-3301 (2023)
3.
Delker, A.* et al.: Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging. Eur. J. Nucl. Med. Mol. Imaging 50, 1280-1290 (2023)
4.
Noltes, M.E.* et al.: Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography. Eur. J. Nucl. Med. Mol. Imaging 50, 2736-2750 (2023)
5.
Solomonidou, N.* et al.: PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. Eur. J. Nucl. Med. Mol. Imaging 50, 2529-2536 (2023)
6.
Spohn, S.K.B.* et al.: Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy. Eur. J. Nucl. Med. Mol. Imaging 50, 2537-2547 (2023)
7.
Barbone, G.E.* et al.: X-ray multiscale 3D neuroimaging to quantify cellular aging and neurodegeneration postmortem in a model of Alzheimer’s disease. Eur. J. Nucl. Med. Mol. Imaging 49, 4338-4357 (2022)
8.
Ma, R. et al.: An encoder-decoder network for direct image reconstruction on sinograms of a long axial field of view PET. Eur. J. Nucl. Med. Mol. Imaging 49, 4464-4477 (2022)
9.
Spohn, S.K.B.* et al.: The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis. Eur. J. Nucl. Med. Mol. Imaging 50, 218-227 (2022)
10.
Fang, H.Y.* et al.: Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett's esophagus. Eur. J. Nucl. Med. Mol. Imaging, DOI: 10.1007/s00259-021-05582-y (2021)
11.
Paprottka, K.J.* et al.: Fully automated analysis combining [18F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of glioma progression. Eur. J. Nucl. Med. Mol. Imaging 48, 4445-4455 (2021)
12.
Kessel, K.A. et al.: Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome. Eur. J. Nucl. Med. Mol. Imaging 47, 1391-1399 (2020)
13.
Peeken, J.C. et al.: A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients. Eur. J. Nucl. Med. Mol. Imaging 47, 2968-2977 (2020)
14.
Schmidt-Hegemann, N.S.* et al.: Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study. Eur. J. Nucl. Med. Mol. Imaging 47, 1852-1863 (2020)
15.
Vogel, M.M. et al.: Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy. Eur. J. Nucl. Med. Mol. Imaging 47, 2328-2338 (2020)
16.
Laitinen, I.* et al.: Assessment of in vivo glucagon receptor engagement in rat liver. Eur. J. Nucl. Med. Mol. Imaging 46, S707-S708 (2019)
17.
Bolch, W.E.* et al.: The ICRP reference pediatric phantoms - design, construction, and applications to nuclear medicine dosimetry. Eur. J. Nucl. Med. Mol. Imaging 45, S79-S79 (2018)
18.
Höllriegl, V. & Li, W.B.: Application of new ICRP biokinetic models for pharmacokinetic modelling of Radium-223 used for treatment of prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 45, S242-S242 (2018)
19.
Karimi Ghodoosi, E. et al.: Comparison of absorbed dose to kidneys using quantitative SPECT/CT and whole body planar images for Lu-177-PSMA I&T in prostate cancer therapy. Eur. J. Nucl. Med. Mol. Imaging 45, S112-S113 (2018)
20.
Li, W.B. et al.: Feasibility study of applying ICRP biokinetic models for pharmacokinetic modelling of alpha-emitter thorium-227 used in targeted radionuclide therapy. Eur. J. Nucl. Med. Mol. Imaging 45, S125-S125 (2018)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮